Clinical Trials Logo

Immune-Mediated Colitis clinical trials

View clinical trials related to Immune-Mediated Colitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04797325 Recruiting - Clinical trials for Immune-Mediated Colitis

Vedolizumab for Immune Mediated Colitis

Start date: August 30, 2021
Phase: Phase 2
Study type: Interventional

This is an open label randomized trial to evaluate the efficacy and treatment duration with vedolizumab to patients with immune mediated colitis. The trial will include 82 patients randomized into two arms, either standard treatment with prednisolone (plus infliximab in severe cases) or vedolizumab treatment up front.

NCT ID: NCT04768504 Recruiting - Clinical trials for Immune-Mediated Colitis

Tofacitinib for the Treatment of Refractory Immune-related Colitis From Checkpoint Inhibitor Therapy- TRICK Study

Start date: March 22, 2022
Phase: Phase 2
Study type: Interventional

This is a single-arm pilot study evaluating the efficacy and safety of tofacitinib in cancer patients with immune-related colitis from immune checkpoint inhibitor (ICI) therapy.